Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
624天前
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
890天前
U.S. Trade Deficit Surges Much More Than Expected In March
The U.S. trade deficit spiked by much more than expected in the month of March, according to a report released by the Commerce Department on Tuesday.
RTTNews
|
25分钟前
Bay Street Likely To Open On Mixed Note
Canadian shares may be weighed down on Tuesday by U.S. President Donald Trump's announcement on Monday that he is likely to announce pharmaceutical tariffs soon. The Federal Reserve's monetary policy announcement, due on Wednesday, is also in focus.
However, higher crude oil and metal prices could trigger some buying in energy and materials space.
RTTNews
|
37分钟前
Philips Cuts FY25 Margin View On Tariffs, Despite Higher Q1 Income, Orders; Stock Down
Shares of Royal Philips N.V. were losing around 3 percent in the mid-day trading in Amsterdam, as well as around 5 percent in pre-market activity on the NYSE, after the Dutch consumer electronics giant on Tuesday trimmed its margin forecast for fiscal 2025 to reflect the estimated net tariff impact of 250 million euros to 300 million euros. Further, the firm maintained annual sales view,...
RTTNews
|
1小时41分钟前
FTSE 100 Down Slightly As Stocks Turn In Mixed Performance
U.K. stocks are turning in a mixed performance in cautious trade on Tuesday with traders back to trading after a long weekend. Investors are awaiting the monetary policy announcements from the Federal Reserve and the Bank of England, due on Wednesday and Thursday, respectively.
RTTNews
|
1小时42分钟前
Yen Rises Amid Risk-off Mood
The Japanese yen strengthened against other major currencies in the European on Tuesday, as European stocks traded lower as investors assessed the latest batch of earnings and awaited upcoming Fed and BoE meetings.
RTTNews
|
1小时53分钟前
Australian Dollar Falls On Weak Chinese PMI Data
The Australian dollar weakened against other major currencies in the European session on Tuesday, after China's service sector grew at the slowest pace in seven months in April as disruptions to goods trade amid fresh tariffs negatively impacted new work of some service providers.
RTTNews
|
2小时14分钟前
